Clinical Research in Gastroenterology 2

Inflammatory bowel disease - i.e. ulcerative colitis and Crohn''s disease - not only creates significant patient morbidity but also imposes a diagnostic and therapeutic challenge to the physician in charge of these patients. Since the development of sulphasalazine by Dr Nanna Svartz in Sweden half a century ago, important improvements in the prognosis of ulcerative colitis and Crohn''s disease hav...